IFP Advisors, Inc - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 33 filers reported holding INMUNE BIO INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of INMUNE BIO INC
ValueSharesWeighting
Q3 2023$1,246
-60.3%
184
-50.0%
0.00%
Q2 2023$3,141
+113.7%
368
+100.0%
0.00%
Q1 2023$1,470
+73400.0%
184
-50.0%
0.00%
Q4 2022$2
-99.8%
368
+100.0%
0.00%
Q3 2022$1,0000.0%1840.0%0.00%
Q2 2022$1,000
-50.0%
184
-50.0%
0.00%
Q1 2022$2,0000.0%368
+100.0%
0.00%
Q4 2021$2,000
-66.7%
184
-35.2%
0.00%
Q3 2021$6,000
+100.0%
284
+54.3%
0.00%
Q2 2021$3,000
+50.0%
1840.0%0.00%
Q1 2021$2,0001840.00%
Other shareholders
INMUNE BIO INC shareholders Q1 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 275,000$5,341,0002.77%
Fermata Advisors, LLC 12,830$249,0000.11%
DG Capital Management, LLC 20,000$388,0000.08%
YorkBridge Wealth Partners, LLC 10,369$201,0000.05%
Ikarian Capital, LLC 26,632$517,0000.04%
Financial Advocates Investment Management 16,667$324,0000.02%
Janney Montgomery Scott LLC 99,323$1,929,0000.01%
Belvedere Trading LLC 16,177$302,0000.01%
FNY Investment Advisers, LLC 800$15,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 17,200$334,0000.01%
View complete list of INMUNE BIO INC shareholders